Document Detail


Economic evaluation of quality assurance programmes.
MedLine Citation:
PMID:  10144391     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Substantial investments are now being made in quality assurance programmes throughout the developed world. Proposes that economic evaluation is one approach to justifying these in terms of value for money. Three key elements are: comparison with some alternative course of action; measurement of costs; and measurement of consequences. Illustrates the difficulties of addressing these by a case-study--an audit programme aiming to increase the use of intravenous thrombolysis for acute myocardial infarction. Discusses the production of accurate costings; the wide confidence limits associated with regression analysis; and the numerous assumptions required in the modelling of effectiveness. Economic evaluation of quality assurance programmes may be useful in future, if the required data can be collected.
Authors:
M B Robinson
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of health care quality assurance     Volume:  8     ISSN:  0952-6862     ISO Abbreviation:  Int J Health Care Qual Assur     Publication Date:  1995  
Date Detail:
Created Date:  1995-09-21     Completed Date:  1995-09-21     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8916799     Medline TA:  Int J Health Care Qual Assur     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  8-12     Citation Subset:  H    
Affiliation:
Nuffield Institute for Health, Leeds, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cost-Benefit Analysis
Great Britain
Health Services Research
Hospital Costs
Humans
Models, Economic
Myocardial Infarction / drug therapy,  economics*
Program Evaluation
Quality Assurance, Health Care / economics*
Thrombolytic Therapy / economics*,  standards,  utilization

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Complaints management--in-depth review.
Next Document:  Long-term care and the private insurance market.